S Mark Hall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
S Mark Hall has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alice Z Perazzini
CEA, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, Via Bologna 148, 10154, Turin, Italy
1 shared publication - Amir N. Hamir
National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, IA, USA
1 shared publication - Barbara Iulini
Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle D’Aosta, Via Bologna 148, 10154 Turin, Italy
1 shared publication - Chiara Porcario
CEA, Italian Reference Laboratory for TSEs, Neuroscienze - Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, Via Bologna 148, 10154 Torino, Italy
1 shared publication - Christina M. Loiacono
United States Department of Agriculture
1 shared publication - Cristiano Corona
Affiliation SS. Neurobiologia sperimentale, Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d’Aosta, Turin, Italy
1 shared publication
Latest Publications
- Open Access
- 29 September 2011
- Published by Springer Nature in BMC Research Notes
- Vol. 4 (1) , 376
Evaluation of two sets of immunohistochemical and Western blot confirmatory methods in the detection of typical and atypical BSE cases
Three distinct forms of bovine spongiform encephalopathy (BSE), defined as classical (C-), low (L-) or high (H-) type, have been detected through ongoing active and passive surveillance systems for the disease.
- 29 September 2011
- Published by Springer Nature in BMC Research Notes
- Vol. 4 (1) , 376
Open AccessEvaluation of two sets of immunohistochemical and Western blot confirmatory methods in the detection of typical and atypical BSE cases
Three distinct forms of bovine spongiform encephalopathy (BSE), defined as classical (C-), low (L-) or high (H-) type, have been detected through ongoing active and passive surveillance systems for the disease.